Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 3221 of 5804
-
Could a simple oxygen device improve brain death diagnosis?
Knowledge-focused Not yet recruitingBrain death (BD) is characterized by a severe brain injury resulting in irreversible loss of all brain and brainstem functions, while other organs may remain viable. The diagnosis of BD is based on the presence of coma, absence of brainstem reflexes, and absence of spontaneous br…
Phase: NA • Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
New blood test may predict bleeding risk after heart surgery
Knowledge-focused Not yet recruitingThe goal of this observational study is to learn how flow-based platelet function measured with the Total Thrombus-formation Analysis System (T-TAS) relates to early postoperative bleeding in adults undergoing cardiac surgery with cardiopulmonary bypass. The study will also evalu…
Sponsor: Hospital de la Santa creu i Sant Pau - Barcelona • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can oxygen or light heal breastfeeding nipple cracks?
Symptom relief Not yet recruitingThe World Health Organization and UNICEF define the protection and support of breastfeeding as one of the key determinants of maternal and newborn health. Nipple cracks are common in the postpartum period and cause breastfeeding problems. If not addressed early, they can lead to …
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New foam could offer relief for rare skin bumps
Symptom relief Not yet recruitingThis proof-of-concept trial evaluates the efficacy, safety, and patient satisfaction of topical minocycline foam (AMZEEQ®) in patients aged 9 and older with confluent and reticulated papillomatosis (CARP). Participants will apply AMZEEQ® to one side of the body and a topical emol…
Phase: EARLY_PHASE1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New drug HBM7020 tested in humans for first time against autoimmune diseases
Disease control Not yet recruitingThis first-in-human study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of HBM7020. The study will enroll healthy participants at low doses, followed by participants with moderate to severe autoimmune diseases with predominant B-cell i…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New support program aims to help young people stop laughing gas misuse
Symptom relief Not yet recruitingNitrous oxide (laughing gas, N₂O) is the third most commonly used recreational drug among young people in the UK. Although it may seem harmless, frequent use can damage the nerves and spinal cord. Vitamin B12 injections can help treat these neurological complications, but continu…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New imaging agent may help doctors see which lung tumors are still growing during immunotherapy
Knowledge-focused Not yet recruitingThis phase I trial studies the safety and side effects of a new positron emission tomography (PET) imaging agent called 64Cu-DOTA-pembrolizumab to see how well it works in determining treatment response for patients with stage IV non-small cell lung cancer (NSCLC) already receivi…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Can a single drug free patients from insulin after immunotherapy?
Disease control Not yet recruitingTo find out if taking a drug called infliximab (the "study drug") is safe and effective in reversing insulin dependence in CIADM.
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New registry to track COPD Patients' daily struggles and treatments
Knowledge-focused TerminatedThis registry will collect data on COPD, including the course of disease, treatment patterns, and potential new therapies. The registry will also track the experience of participants and caregivers in clinical practice.
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could a bike ride help your brain? new study explores exercise, cell health, and depression
Knowledge-focused Not yet recruitingDepression is a common mental health condition that affects millions of people worldwide and is a leading cause of disability. Although current treatments can be effective, many patients do not fully recover or experience long-term improvement. This study aims to better understan…
Phase: NA • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New study asks: is this glucose monitor a Game-Changer for diabetes?
Knowledge-focused Not yet recruitingThis is an open-label, prospective, multicenter observational study designed to evaluate the perceived benefits, device experience, preference, and glucose-related parameters associated with the Instara-1 Continuous Glucose Monitoring device. The study will include patients with …
Sponsor: Getz Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Promising leukemia drug tested as maintenance after transplant in kids
Disease control TerminatedThis phase I trial tests the safety, best dose, and effectiveness of revumenib given as maintenance therapy after standard hematopoietic stem cell transplant (HSCT) in patients with acute lymphoblastic leukemia, acute myeloid leukemia, or mixed phenotype acute leukemia. Revumenib…
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Legume power: daily pulses may boost gut and metabolic health
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to learn whether daily intake of lactic acid bacteria fermented or unfermented legumes can improve metabolic and gut health in healthy adults. The main questions it aims to answer are: * Does eating 100 g per day of legumes for 2 weeks lower b…
Phase: NA • Sponsor: University College Absalon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can we predict a rare but dangerous kidney artery complication after stone surgery?
Knowledge-focused Not yet recruitingIn a multicenter retrospective study, to assess the incidence and risk factors of renal artery pseudoaneurysm after percutaneous nephrolithotomy, and to characterize the clinical presentation and treatment outcomes.
Sponsor: Botkin Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Butter vs. skim: which dairy is better for your heart?
Knowledge-focused Not yet recruitingThe purpose of this study is to find out if full-fat dairy and low-fat dairy have similar effects on risk factors for heart disease and diabetes. During the study, participants will consume two types of dairy products: low-fat dairy (milk, yogurt, and cheese) and full-fat dairy (…
Phase: NA • Sponsor: Penn State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Simple sleep aids may cut delirium after heart surgery
Symptom relief Not yet recruitingCoronary artery bypass grafting is the most commonly performed surgical procedure among cardiovascular diseases. Nursing care for patients undergoing cardiac surgery involves a process that includes preoperative preparation and subsequent close monitoring of neurological, cardiac…
Phase: NA • Sponsor: Necmettin Erbakan University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Text message advice could keep kids with fever out of the ER
Symptom relief Not yet recruitingDuring the winter of 2022/23, a standardized protocol for managing fever in children aged 3 months to 10 years was implemented at Annecy Genevois Hospital for a period of one month. This protocol included advice given by the regulator and sending a text message to parents after t…
Phase: NA • Sponsor: Centre Hospitalier Annecy Genevois • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New immune clues could unlock better b-cell cancer treatments
Knowledge-focused Not yet recruitingInhibitory immune receptors, including CD85d and CD305 (LAIR-1), act as immune checkpoint-like molecules. They contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit SH2-domain phosphatases (e.g., SHP-1), which suppress cellular activation (7,8). CD85d is p…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Can a 'N-of-1' trial help heart failure patients find their perfect dose?
Knowledge-focused Not yet recruitingIn this study we seek to understand whether N-of-1 trials using a crossover withdrawal/reversal design with as many 2-week periods can be used to identify the highest tolerated beta-blocker dose for patients with Heart Failure with Reduced Ejection Fraction (HFrEF). To achieve th…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New lupus pill ONT01 enters human safety trials
Disease control Recruiting nowONT01 is a drug that is being studied for the treatment of Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) and is not approved by the FDA. The purpose of this study is to better determine whether ONT01 is safe and tolerated by people with lupus nephritis or SLE. The s…
Phase: EARLY_PHASE1 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC